Put companies on watchlist
MPH Health Care AG
ISIN: DE000A289V03
WKN: A289V0
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

MPH Health Care AG · ISIN: DE000A289V03 · EQS - Company News (41 News)
Country: Germany · Primary market: Germany · EQS NID: 1342773
04 May 2022 08:00AM

MPH Health Care AG: Supervisory Board approves 2021 annual financial statements


DGAP-News: MPH Health Care AG / Key word(s): Annual Results
MPH Health Care AG: Supervisory Board approves 2021 annual financial statements

04.05.2022 / 08:00
The issuer is solely responsible for the content of this announcement.


Supervisory Board of MPH Health Care approves 2021 annual financial statements

Berlin, 4 May 2022: At its meeting yesterday, the Supervisory Board of MPH Health Care AG (ISIN: DE000A289V03) approved the annual financial statements of MPH Health Care (individual financial statements in accordance with the German Commercial Code (HGB) and consolidated financial statements in accordance with IFRS), which were issued with an unqualified audit certificate. The preliminary figures already communicated were confirmed in full. Equity decreased from 201.3 million euros to 192.3 million euros. The net asset value (NAV) per share fell slightly from 47.01 euros (31.12.2020) to 44.92 euros as of 31.12.2021.

In order to have sufficient financial leeway for the further expansion of the investments, the Supervisory Board and Executive Board decided in its meeting yesterday to propose to the Annual General Meeting that the balance sheet profit for the past financial year 2021 be carried forward in full to new account.

The Annual Report 2021 of MPH Health Care AG will be published on 24 May 2022. The Annual General Meeting, which is planned to be held in person, will take place on 14 July 2022 in Berlin.

About MPH Health Care AG:

MPH Health Care AG is an investment company with a strategic focus on the acquisition, development and sale of companies and company shares, particularly in growth segments of the healthcare market. This includes both insurance-financed and privately financed segments. However, MPH also exploits potential from high-growth and high-profit sectors outside the healthcare market. MPH Health Care AG is listed on the Basic Board (Open Market) of the Frankfurt Stock Exchange.


Contact:
Patrick Brenske, Management Board
Corporate Communications
E-Mail: ir@mph-ag.de


04.05.2022 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: MPH Health Care AG
Grünauer Straße 5
12557 Berlin
Germany
Phone: 030 / 863 21 45 60
Fax: 030 / 863 21 45 69
E-mail: info@mph-ag.de
Internet: www.mph-ag.de
ISIN: DE000A289V03, DE000A289VT5
WKN: A289V0
Listed: Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Basic Board), Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1342773

 
End of News DGAP News Service

1342773  04.05.2022 

fncls.ssp?fn=show_t_gif&application_id=1342773&application_name=news&site_id=boersengefluester_html
Visual performance / price development - MPH Health Care AG
Smart analysis and research tools can be found here.

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2024
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.